|
|
Professor Zhou Hua’s experience in treating atrial fibrillation based on staged dialectical theory |
TANG Qiaolin QU Huiyan LIU Wenrui YANG Tianshu YANG Tao ZHOU Hua |
Department of Cardiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
|
|
|
Abstract Atrial fibrillation is one of the most common arrhythmias characterized with high morbidity, disability, and mortality in the clinical field. Professor Zhou Hua believes that atrial fibrillation is the syndrome of deficiency of root case and excess of manifestation. The deficiency of root case is mainly caused by deficiency of qi, blood, yin and yang, the excess of manifestation is mainly phlegm and blood stasis. In terms of treatment, it is emphasized that treatment should be carried out by three stages, including early stage, middle stage, and late stage. At the early stage, the heart’s qi and yin injuries are the key to its pathogenesis, and the treatment is mainly to replenish qi and nourish yin. In the middle stage, phlegm and blood stasis are caused by deficiency of heart and spleen, which should be treated by resolving phlegm, removing blood stasis, and strengthening the spleen. In the later stage, the deficiency of heart and kidney yang caused by the injury of kidney qi is an important reason for the disease to persist and worsen, treat with warming yang and tonifying kidney.
|
|
|
|
|
[1] 王拥军,李子孝,谷鸿秋,等.中国卒中报告2020(中文版)(1)[J].中国卒中杂志,2022,17(5):433-447.
[2] Staerk L,Sherer JA,Ko D,et al. Atrial fibrillation:epidemiology,pathophysiology,and clinical outcomes [J]. Circ Res,2017,120(9):1501-1517.
[3] 胡志成,蒋超,郑黎晖,等.2019年中国心房颤动医疗质量控制报告[J].中国循环杂志,2020,35(5):427-437.
[4] Sultan A,Lüker J,Andresen D,et al. Predictors of atrial fibrillation recurrence after catheter ablation:data from the german ablation registry [J]. Sci Rep,2017,7(1):16678.
[5] 史宏岩,林文华.胺碘酮的肺毒性及防治[J].实用老年医学,2016,30(10):863-864.
[6] 刘茜,周华,瞿惠燕,等.周华教授基于“从肾治心”理论分阶段治疗慢性心力衰竭经验[J].中西医结合心脑血管病杂志,2022,20(3):563-565.
[7] 刘文锐,瞿惠燕,王田,等.周华教授基于“阳微阴弦”病机理论论治心力衰竭经验总结[J].中国医药导报,2022, 19(9):132-135.
[8] 王茹,王培利,王承龙.房颤的中医研究进展[J].辽宁中医杂志,2020,47(6):213-216.
[9] 张瑞,魏陵博.中医药治疗心房颤动的临床研究进展[J].中西医结合心脑血管病杂志,2019,17(19):2962-2964.
[10] 郇家铭,王宁,李运伦,等.全国名中医丁书文益气活血解毒法治疗心房颤动的处方用药规律挖掘[J].世界科学技术-中医药现代化,2020,22(12):4094-4102.
[11] 李进,李春岩,史载祥,等.史载祥治疗冠心病房颤经验总结[J].中华中医药杂志,2018,33(9):3948-3951.
[12] 黄力.中西医结合在心房颤动治疗中的优势[J].中国中西医结合杂志,2020,40(3):358-360.
[13] 赵全如,谢晓燕.丹参的化学成分及药理作用研究进展[J].广东化工,2021,48(1):57-59.
[14] 付琳,付强,李冀,等.黄连化学成分及药理作用研究进展[J].中医药学报,2021,49(2):87-92.
[15] Qiu H,Liu W,Lan T,et al. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats [J]. Phytomedicine,2018,51:255-265.
[16] Zheng H,Zhu F,Miao P,et al. Antimicrobial natural product berberine is efficacious for the treatment of atrial fibrillation [J]. Biomed Res Int,2017,2017:3146791.
[17] Zhou ZW,Zheng HC,Zhao LF,et al. Effect of berberine on acetylcholine-induced atrial fibrillation in rabbit [J]. Am J Transl Res,2015,7(8):1450-1457.
[18] 于兆欣,罗斌玉,冯晓敬.从痰瘀互结论治房颤[J].环球中医药,2020,13(4):666-668.
[19] 刘宗昆,张翠萍,陈荣幸,等.从痰瘀互结角度论治房颤[J].影像研究与医学应用,2017,1(2):219-220.
[20] 简鹏,李庆海,范立华.甘松新酮对快速性心律失常大鼠心肌细胞抑制作用的实验研究[J].中国临床药理学杂志,2015,31(22):2240-2242.
[21] 张萍,徐凤芹,马晓昌,等.延胡索碱治疗快速性心律失常的研究进展[J].中国中西医结合杂志,2012,32(5):713-716.
[22] 杨涛,胡朗吉,葛郁芝.中药甘松抗心律失常作用及其电生理机制研究[J].现代诊断与治疗,2008,19(5):276- 278.
[23] 解微微,高佳明,石羡茹,等.从心律失常与心衰并发症的最新临床进展解析中医治疗“脉结代,心动悸”的科学内涵[J].中草药,2018,49(22):5448-5455.
[24] 瞿惠燕,杨天舒,杨晓利,等.鹿芪颗粒对急性心肌梗死大鼠心功能及血清内毒素水平影响的实验研究[J].上海中医药杂志,2019,53(4):61-64.
[25] Qu H,Feng Z,Li Z,et al. Induction of substantial myocardial regeneration by an active fraction of the Chinese herb Rosa laevigata Michx [J]. BMC Complement Altern Med,2015,15:359. |
|
|
|